Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,822 | 28,819 | 43,497 | 48,705 | 57,221 |
| Receivables | 628 | 2 | 0 | 0 | 0 |
| TOTAL | $29,276 | $31,018 | $45,982 | $51,407 | $60,024 |
| Non-Current Assets | |||||
| PPE Net | 13,740 | 10,277 | 10,097 | 9,847 | 10,108 |
| Other Non-Current Assets | 9,304 | 13,662 | 12,056 | 10,686 | 10,340 |
| TOTAL | $23,044 | $23,939 | $22,153 | $20,533 | $20,448 |
| Total Assets | $52,320 | $54,956 | $68,135 | $71,940 | $80,471 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,735 | 7,349 | 11,135 | 7,645 | 5,101 |
| TOTAL | $13,474 | $8,215 | $12,902 | $8,227 | $5,660 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 8,000 | 182 | 1,146 | N/A | N/A |
| Other Non-Current Liabilities | 10,820 | 11,036 | 11,248 | 11,431 | 11,568 |
| TOTAL | $10,820 | $11,036 | $11,248 | $11,431 | $11,568 |
| Total Liabilities | $24,294 | $19,250 | $24,150 | $19,658 | $17,228 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,360 | 8,360 | 8,308 | 8,308 | 8,308 |
| Common Shares | 84 | 84 | 8 | 83 | 83 |
| Retained earnings | -417,273 | -408,029 | -398,118 | -388,355 | -375,926 |
| TOTAL | $28,026 | $35,706 | $43,986 | $52,282 | $63,243 |
| Total Liabilities And Equity | $52,320 | $54,956 | $68,135 | $71,940 | $80,471 |